The mechanisms of GBM-associated epilepsy are linked to the reduction of KCC2 activity in the peritumoral region, leading to impaired GABAergic inhibition, and they suggest that modulating [Cl−]i homeostasis by activating KCC2 may help control seizures [63]. Here, SLC12A5 is linked to epilepsy.